Gmax Biopharm

About:

Gmax Biopharm develops GPCR antibody therapeutics for unmet medical needs in cardiovascular diseases, metabolic disorders, and cancer.

Website: http://www.gmaxbiopharm.com/

Top Investors: Cowin Capital, China Merchants Group, Tigermed, Brill Capital

Description:

Gmax Biopharm develops GPCR antibody therapeutics for unmet medical needs in cardiovascular diseases, metabolic disorders, and cancer. Gmax Biopharm develops a proprietary platform with a systemic approach to GPCR MAb generation, screening, and development. Gmax Biopharm enables antibody screening, humanization, and engineering to produce antibody candidates with high drugability and developability.